Sign in
4

Changes in Ownership

Seaport Therapeutics, Inc. Filed Acc 0001193125-26-204507

Options or other derivatives

  • Chief Executive Officer acquired 1,758,599 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zohar Daphne · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +271,813 271,813 D
2026-04-30 Grant or award : show line 2 in the form Stock Option (Right to Buy) +1,486,786 1,486,786 D
Loading xslF345X06/ownership.xml…